Comparative evaluation of central serous retinopathy in pilots and non-pilot patients

Background: Central serous chorioretinopathy (CSC) is a disqualifying condition for pilots because of the importance of good vision to their jobs. The objective of this study was to evaluate the clinical diagnosis, treatment, and aviation medical assessment principles for CSC in military pilots. Met...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan-Yan Zhao, Hua Wang, Wei Chen, Quan Wang, Yong Liu
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Photodiagnosis and Photodynamic Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1572100024004137
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850245265510891520
author Yan-Yan Zhao
Hua Wang
Wei Chen
Quan Wang
Yong Liu
author_facet Yan-Yan Zhao
Hua Wang
Wei Chen
Quan Wang
Yong Liu
author_sort Yan-Yan Zhao
collection DOAJ
description Background: Central serous chorioretinopathy (CSC) is a disqualifying condition for pilots because of the importance of good vision to their jobs. The objective of this study was to evaluate the clinical diagnosis, treatment, and aviation medical assessment principles for CSC in military pilots. Methods: The clinical data and aviation medical assessments of 15 pilots with CSC who were admitted to the Air Force Medical Center between January 2003 and December 2021 were analyzed, and three typical cases were reported. The relevant literature evaluation was conducted on 32 non-pilot patients with CSC. Results: The mean age of the 15 pilots was 37.47 ± 4.21 years, and they were all male. Fourteen were affected in a single eye (4 in the right eye and 10 in the left eye), while one was affected in both eyes. Two pilots were nonsmokers and did not consume alcohol; one was a smoker; four pilots consumed alcohol on a regular basis; and eight pilots were smokers and consumed alcohol on a regular basis. The mean best-corrected visual acuity (BCVA) increased from 0.83 ± 0.33 at the initial visit to 0.95 ± 0.44 at the final visit. The non-pilot group included 32 patients, 29 of whom were male and 3 of whom were female, with a mean age of 37.16 ± 10.02 years. Thirty-one patients had single-eye involvement (17 of the right eye and 14 of the left eye), while one patient had involvement of both eyes. Seventeen patients were nonsmokers and did not consume alcohol; two were smokers; four consumed alcohol on a regular basis; and nine were smokers and consumed alcohol on a regular basis. The mean BCVA increased from 0.64 ± 0.28 at the first visit to 0.90 ± 0.30 at the final visit. Patients in the pilot group had a high recurrence rate, which was associated with a low final BCVA and led to their disqualification from flying. Conclusion: Pilot and non-pilot patients did not differ significantly in terms of CSC clinical data. Chronic and recurrent CSC can be a vision-threatening disease; therefore, pilots must receive accurate and timely diagnosis.
format Article
id doaj-art-dc0f62c9a605425888fba8acc8a5ebbd
institution OA Journals
issn 1572-1000
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Photodiagnosis and Photodynamic Therapy
spelling doaj-art-dc0f62c9a605425888fba8acc8a5ebbd2025-08-20T01:59:30ZengElsevierPhotodiagnosis and Photodynamic Therapy1572-10002024-12-015010437610.1016/j.pdpdt.2024.104376Comparative evaluation of central serous retinopathy in pilots and non-pilot patientsYan-Yan Zhao0Hua Wang1Wei Chen2Quan Wang3Yong Liu4Department of Ophthalmology, Air Force Medical Center, PLA, Beijing 100142, PR ChinaDepartment of Ophthalmology, Air Force Medical Center, PLA, Beijing 100142, PR ChinaDepartment of Ophthalmology, Air Force Medical Center, PLA, Beijing 100142, PR ChinaDepartment of Ophthalmology, Air Force Medical Center, PLA, Beijing 100142, PR ChinaCorresponding author. Department of Ophthalmology, Air Force Medical Center, PLA, No.30, Fucheng Road, Haidian District, Beijing 100142, PR China.; Department of Ophthalmology, Air Force Medical Center, PLA, Beijing 100142, PR ChinaBackground: Central serous chorioretinopathy (CSC) is a disqualifying condition for pilots because of the importance of good vision to their jobs. The objective of this study was to evaluate the clinical diagnosis, treatment, and aviation medical assessment principles for CSC in military pilots. Methods: The clinical data and aviation medical assessments of 15 pilots with CSC who were admitted to the Air Force Medical Center between January 2003 and December 2021 were analyzed, and three typical cases were reported. The relevant literature evaluation was conducted on 32 non-pilot patients with CSC. Results: The mean age of the 15 pilots was 37.47 ± 4.21 years, and they were all male. Fourteen were affected in a single eye (4 in the right eye and 10 in the left eye), while one was affected in both eyes. Two pilots were nonsmokers and did not consume alcohol; one was a smoker; four pilots consumed alcohol on a regular basis; and eight pilots were smokers and consumed alcohol on a regular basis. The mean best-corrected visual acuity (BCVA) increased from 0.83 ± 0.33 at the initial visit to 0.95 ± 0.44 at the final visit. The non-pilot group included 32 patients, 29 of whom were male and 3 of whom were female, with a mean age of 37.16 ± 10.02 years. Thirty-one patients had single-eye involvement (17 of the right eye and 14 of the left eye), while one patient had involvement of both eyes. Seventeen patients were nonsmokers and did not consume alcohol; two were smokers; four consumed alcohol on a regular basis; and nine were smokers and consumed alcohol on a regular basis. The mean BCVA increased from 0.64 ± 0.28 at the first visit to 0.90 ± 0.30 at the final visit. Patients in the pilot group had a high recurrence rate, which was associated with a low final BCVA and led to their disqualification from flying. Conclusion: Pilot and non-pilot patients did not differ significantly in terms of CSC clinical data. Chronic and recurrent CSC can be a vision-threatening disease; therefore, pilots must receive accurate and timely diagnosis.http://www.sciencedirect.com/science/article/pii/S1572100024004137Central serous chorioretinopathy (CSC)Intravitreal bevacizumab injectionPilotPhotodynamic therapy (PDT)Waiver
spellingShingle Yan-Yan Zhao
Hua Wang
Wei Chen
Quan Wang
Yong Liu
Comparative evaluation of central serous retinopathy in pilots and non-pilot patients
Photodiagnosis and Photodynamic Therapy
Central serous chorioretinopathy (CSC)
Intravitreal bevacizumab injection
Pilot
Photodynamic therapy (PDT)
Waiver
title Comparative evaluation of central serous retinopathy in pilots and non-pilot patients
title_full Comparative evaluation of central serous retinopathy in pilots and non-pilot patients
title_fullStr Comparative evaluation of central serous retinopathy in pilots and non-pilot patients
title_full_unstemmed Comparative evaluation of central serous retinopathy in pilots and non-pilot patients
title_short Comparative evaluation of central serous retinopathy in pilots and non-pilot patients
title_sort comparative evaluation of central serous retinopathy in pilots and non pilot patients
topic Central serous chorioretinopathy (CSC)
Intravitreal bevacizumab injection
Pilot
Photodynamic therapy (PDT)
Waiver
url http://www.sciencedirect.com/science/article/pii/S1572100024004137
work_keys_str_mv AT yanyanzhao comparativeevaluationofcentralserousretinopathyinpilotsandnonpilotpatients
AT huawang comparativeevaluationofcentralserousretinopathyinpilotsandnonpilotpatients
AT weichen comparativeevaluationofcentralserousretinopathyinpilotsandnonpilotpatients
AT quanwang comparativeevaluationofcentralserousretinopathyinpilotsandnonpilotpatients
AT yongliu comparativeevaluationofcentralserousretinopathyinpilotsandnonpilotpatients